ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 106 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 12.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $28,000 | -55.6% | 28,097 | -35.9% | 0.00% | – |
Q1 2022 | $63,000 | -69.0% | 43,835 | +466.4% | 0.00% | – |
Q4 2017 | $203,000 | -51.9% | 7,739 | -58.8% | 0.00% | -100.0% |
Q3 2017 | $422,000 | -42.5% | 18,789 | -30.0% | 0.00% | 0.0% |
Q2 2017 | $734,000 | +62.7% | 26,855 | +44.0% | 0.00% | 0.0% |
Q1 2017 | $451,000 | +37.1% | 18,647 | +17.8% | 0.00% | – |
Q4 2016 | $329,000 | +15.0% | 15,832 | +19.0% | 0.00% | -100.0% |
Q4 2015 | $286,000 | -13.6% | 13,309 | -35.0% | 0.00% | 0.0% |
Q3 2015 | $331,000 | -57.0% | 20,469 | -31.3% | 0.00% | -50.0% |
Q2 2015 | $769,000 | -18.7% | 29,807 | -29.1% | 0.00% | 0.0% |
Q1 2015 | $946,000 | -1.9% | 42,039 | -16.3% | 0.00% | 0.0% |
Q4 2014 | $964,000 | -21.2% | 50,243 | -11.8% | 0.00% | -33.3% |
Q3 2014 | $1,223,000 | -7.5% | 56,939 | +12.0% | 0.00% | -25.0% |
Q2 2014 | $1,322,000 | +70.6% | 50,839 | +43.1% | 0.00% | +100.0% |
Q1 2014 | $775,000 | +265.6% | 35,539 | +105.0% | 0.00% | +100.0% |
Q4 2013 | $212,000 | – | 17,339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |